Preliminary Program

Print
THURSDAY 19 MAY, 2016
19:00-20:00 Registration and Welcome

FRIDAY 20 MAY, 2016
07:30-08:00 Breakfast Buffet
 
Hall A
08:00-09:00 SATELLITE SYMPOSIUM A
Hall B
08:00-09:00 SATELLITE SYMPOSIUM B
 
Hall C
08:00-09:00 SATELLITE SYMPOSIUM C
09:00-09:20
Coffee & Refreshments
 
Hall A
09:20-10:20 SATELLITE SYMPOSIUM D
 
Hall B
09:20-10:20 SATELLITE SYMPOSIUM E
 
Hall C
09:20-10:20 SATELLITE SYMPOSIUM F
10:20-12:00 PLENARY SESSION 1 | Therapy in the Treatment of Type 2 Diabetes
10:20-10:25 Chairpersons: Itamar Raz, Israel, Ning Guang, China and Ji Lilong, China
10:25-10:45 The present and future of drug therapy: Ralph DeFronzo, USA
10:45-11:05 Personalized therapy by genotype and phenotype: Juliana Chan, Hong Kong
11:05-11:25 Traditional Chinese Medicine: Ji Linong , China
11:25-11:45 Diabetes in China: how to turn the tide: Fabio Scano, Italy/China
11:45-12:00 Discussion
12:00-12:10
Lunch Box Pick Up

Hall A

12:10-13:10 PLENARY SESSION 2 | SGLT2 New Paragigm in the treatment of Type 2 Diabetes
12:10-12:20 Chairpersons: Francis Chow, Hong Kong and Ralph DeFronzo, USA
12:20-12:40 SGLT2 inhibitors mode of action efficacy and safety: Ajay Kumar, India
12:40-13:00 Cardiovascular outcome studies present and future: Juliana Chan, Hong Kong
13:00-13:10 Discussion
13:10-13:30
Technical Break
 
Hall A
13:30-14:30 SATELLITE SYMPOSIUM G
 
Hall B
13:30-14:30 SATELLITE SYMPOSIUM H
 
Hall C
13:30-14:30 SATELLITE SYMPOSIUM I
14:30-14:40
Technical Break
Hall A
14:40-16:10
SESSION 3 | Kidney: A Target or Solution for Type 2 Diabetes Nephropathy
14:40-14:45 Chairpersons: Ralph DeFronzo, USA and Zeng Zhengpei, China
14:45-15:05 The kidney and its role in glucose homeostasis: Ralph DeFronzo, USA
15:05-15:25 Nutrition support/microuroabuminia: Zeng Zhengpei, China
15:25-15:45 Drug Therapy: Hu Renming, China
15:45-16:10 Discussion
Hall B
14:40-16:10
SESSION 4 | Anti-Diabetic Agents: China vs. The Western World
14:40-14:45 Chairpersons: Itamar Raz, Israel and He Lanjie, China
14:45-15:00 Sulfonylureas and insulin: Philip Home, UK
15:00-15:15 Glucosidase inhibitors: Eberhard Standl, Germany
15:15:15:30 DPP4/GLP1: Paolo Pozzilli, Italy
15:30-15:45 SGLT2: Ajay Kumar, India
15:45-16:00 Comparing the effects of AGI between China and the Western World: Tong Nanwei, China
16:00-16:10 Discussion
Hall C
14:40-16:10
SESSION 5 | Bariatric and Metabolic Surgery 2015
14:40-14:45 Chairpersons: Luc Van Gaal, Belgium and Qu Shen, China
14:45-15:05 Diabetes remission after metabolic surgery: Hong Jie, China
  Only For Obese People
15:05-15:25 Yes: Qu Shen, China
15:25-15:45 No: Luc Van Gaal, Belgium
15:45-16:10 Discussion
16:10-16:30
Coffee & Refreshments
 
Hall A
16:30-18:00
 PLENARY SESSION 6 | Electronic Diabetes Care
16:30-16:35 Chairpersons: Dov Moran, Israel and Zhong Liyong, China
16:35-16:55 Flash glucose monitoring, a novel tool for diabetic management: Ramzi Ajjan, UK
16:55-17:15 Intervention from Smartphone: Awareness, advices or medicine: Dov Moran, Israel
17:15-17:35 Overview of Real World Data Analytics and Digital Patient Engagement in Diabetes: Radhesh Nair, USA
17:35-18:00 Discussion


SATURDAY 21 MAY, 2016
 
Hall A
08:00-09:30 PLENARY SESSION 7 | Gut Microbiota
08:00-08:05 Chairpersons: Karsten Kristiansen, Denmark and Ning Guang, China
08:05-08:25 Gut microbiota and Metabolic Diseases: Karsten Kristiansen, Denmark
08:25-08:45 Gut microbiota and obesity: Luc Van Gaal, Belgium
08:45-09:05 Gut microbiota, diet and nutrition: Eran Elinav, Israel
09:05-09:30 Discussion
09:30-10:00 SATELLITE SYMPOSIUM J
10:00-10:30
Coffee & Refreshments
Hall A
10:30-12:00
SESSION 8 | Initial Use of Combination Therapy
10:30-10:35 Chairpersons: Eberhard Standl, Germany and Peng Yongde, China
Oral (Metformin / DPP4 / SGLT2)
10:35-10:50 Yes: Zhang Yifei, China
10:50-11:05 No: Luc Van Gaal, Belgium
11:05-11:15 Discussion
  Injectable (GLP 1 / Insulin)
11:15-11:30 Yes: Li Yuxiu, China
11:30-11:45 No: Eberhard Standl, Germany
11:45-12:00 Discussion
Hall B
10:30-12:00
SESSION 9 | Novel Insulin Analogues
10:30-10:35 Chairpersons: Philip Home, UK and Chen Gang, China
  Ultra long acting basal insulin – does benefit outweigh cost?
10:35-10:50 Yes: Ajay Kumar, India
10:50-11:05 No: Philip Home, UK
11:05-11:15 Discussion
  Biosimilar in insulin therapy
11:15-11:30
Yes: Ji Linong, China
11:30-11:45 No: Paolo Pozzilli, Italy
11:45-12:00
Discussion
12:00-12:15
Lunch Box Pick Up
 
Hall A
12:15-13:15 SATELLITE SYMPOSIUM K
 
Hall B
12:15:13:15 SATELLITE SYMPOSIUM L
13:15-13:45
Technical Break
 
Hall A
13:45-15:15 SESSION 10 | Benefit of New Therapies for Cardiovascular Diseases
13:45-13:50 Chairpersons: Paolo Pozzilli, Italy and Wang Weiqing, China
13:50-14:10 The Cardiovascular outcome trial-effect on treatment algorithm: Philip Home, UK
14:10-14:30 GLP1/DPP-4 inhibitor: Eberhard Standl, Germany
14:30-14:50 SGLT2: Ji Linong, China
14:50-15:15
Discussion
Hall B
13:45-15:15 SESSION 11 | Type 2 Diabetes and Cancer
13:45-13:50 Chairpersons: Ajay Kumar, India and  Bi Yufan, China
13:50-14:10 Diabetes and cancer - Results from the REACTION study: Bi Yufang, China
14:10-14:50 The global implications of diabetes and its therapy on cancer: Itamar Raz, Israel
14:50-15:15 Panel Discussion
  Itamar Raz, Israel, Ralph DeFronzo, USA, Bi Yufang, China and Eran Elinav, Israel